Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
Authors: Yang, Shih-Yu1 (AUTHOR), Wang, Chih-Chi2 (AUTHOR), Chen, Kuang-Den3 (AUTHOR), Liu, Yueh-Wei2 (AUTHOR), Lin, Chih-Che2 (AUTHOR), Chuang, Ching-Hui4 (AUTHOR), Tsai, Yu-Chieh1 (AUTHOR), Yao, Chih-Chien1 (AUTHOR), Yen, Yi-Hao1 (AUTHOR), Hsiao, Chang-Chun5,6 (AUTHOR), Hu, Tsung-Hui1 (AUTHOR), Tsai, Ming-Chao1,5 (AUTHOR) tony0779@gmail.com
Source: BMC Cancer. 1/14/2021, Vol. 21 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-021-07796-7